Menveo 5 mcg (Meningococcal Group C Oligosaccharide POWDER FOR SOLUTION) 5 MCG

MENVEO 5 MCG is a vaccine designed to protect against meningococcal group C disease. This powder for solution is administered intramuscularly and is manufactured by GlaxoSmithKline Inc.

Strength

5 MCG

Pack Size

0.5ML

Manufacturer / TM Owner

GLAXOSMITHKLINE INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

MENVEO 5 MCG is used to prevent meningococcal group C infections. This vaccine is typically recommended for individuals who are at increased risk of exposure to the meningococcal group C bacteria. It is important to consult with a healthcare provider to determine if this vaccine is suitable for your specific needs.

Side Effects

Common effects of MENVEO 5 MCG may include mild soreness, redness, or swelling at the injection site. Some individuals may also experience mild fever or fatigue following vaccination. These effects are generally temporary and should resolve on their own.

Precautions & Warnings

MENVEO 5 MCG should be stored as directed to maintain its effectiveness. It is important to inform your healthcare provider about any allergies or medical conditions before receiving this vaccine. Always follow the advice of a healthcare professional regarding the administration and handling of this vaccine.

Avoid Interactions

MENVEO 5 MCG may interact with other medications or vaccines. It is important to discuss your current medications and any recent vaccinations with your healthcare provider before receiving this vaccine. Avoid alcohol or other substances that may affect your immune system without consulting a healthcare professional.

Frequently Asked Questions

MENVEO 5 MCG is used to prevent meningococcal group C infections.

MENVEO 5 MCG is administered intramuscularly as a powder for solution.

Common effects may include mild soreness, redness, or swelling at the injection site, as well as mild fever or fatigue.

Individuals with known allergies to any component of the vaccine or those with certain medical conditions should consult a healthcare provider before receiving MENVEO 5 MCG.

It is important to discuss your current medications with a healthcare provider to avoid potential interactions with MENVEO 5 MCG.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.